1. Dandan Wan, Yiliang Yang, Yiyao Liu, Xingli Cun, Man Li, Shanshan Xu, Wei Zhao, Yangyang Xiang, YueQiu, Qianwen Yu, Xian Tang, Zhirong Zhang, Qin He*. Sequential Depletion of Myeloid-derived Suppressor Cells and Tumor Cells with a Dual-pH-Sensitive Conjugated Micelle System for Cancer Chemoimmunotherapy. Journal of Controlled Release,2020, 317, 43-56.
2. Man Li, Mengmeng Li, Yiliang Yang, Yingke Liu, Hanbing Xie, Qianwen Yu, Lifeng Tian, Xian Tang, Kebai Ren, Jianping Li, Zhirong Zhang, Qin He*. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy. Journal of Controlled Release, 2020, 321, 23-35.
3. Yang Long, Zhengze Lu, Shanshan Xu, Man Li, Xuhui Wang, Zhirong Zhang, and Qin He*. Self-Delivery Micellar Nanoparticles Prevent Premetastatic Niche Formation by Interfering with the Early Recruitment and Vascular Destruction of Granulocytic Myeloid-Derived Suppressor Cells. Nano Letters, 2020, 20, 4, 2219-2229.
4. Yashi Wang, Sheng Yin, Lin Mei, Yiliang Yang, Shanshan Xu, Xuan He, Mou Wang, Man Li, Zhirong Zhang, Qin He⁎ A dual receptors-targeting and size-switchable “cluster bomb” co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer. Journal of Controlled Release,2020, 321, 71-83.
5. Yiliang Yang, Yang Long, Yashi Wang, Kebai Ren, Man Li, Zhirong Zhang, Bing Xiang,⁎, Qin He*. Enhanced anti-tumor and anti-metastasis therapy for triple negative breast cancer by CD44 receptor-targeted hybrid self-delivery micelles. International Journal of Pharmaceutics,2020, 577, 119085.
6. Jianping Li, Man Li, Lifeng Tian, Yue Qiu, Qianwen Yu, Xuhui Wang, Rong Guo, Qin He⁎. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy. International Journal of Pharmaceutics,2020, 578, 119122.
7. Qianwen Yu, Yue Qiu, Jianping Li, Xian Tang, Xuhui Wang, Xingli Cun, Shanshan Xu, Yayuan Liu, Man Li, Zhirong Zhang, Qin He*. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy. Journal of Controlled Release, 2020, 321, 564-575.
8. Xuhui Wang, Sheng Yin, Man Li, Jingdong Rao, Dandan Wan, Yue Qiu, Qianwen Yu, Xiaoxiao Chen, Zhengze Lu, Yang Long, Zhirong Zhang, Qin He*. Autophagy inhibition changes the disposition of non-viral gene carriers during blood-brain barrier penetration and enhances TRAIL-induced apoptosis in brain metastatic tumor. Journal of Controlled Release,2020, 321, 497-508.
9. Xuhui Wang, Man Li, Kebai Ren, Chunyu Xia, Jianping Li, Qianwen Yu, Yue Qiu, Zhengze Lu, Yang Long, Zhirong Zhang* and Qin He. On-Demand Autophagy Cascade Amplification Nanoparticles Precisely Enhanced Oxaliplatin-Induced Cancer Immunotherapy. Advanced materials, 2020, 32, 2002160.
10. Yue Qiu, Kebai Ren, Wei Zhao, Qianwen Yu, Rong Guo, Jiao He, Ling Mei, Jiajing Tang, Shanshan Xu, Jianping Li, Jiaojie Wei, Man Li, Zhirong Zhang, Qin He*. A “dual-guide” bioinspired drug delivery strategy of a macrophage-based carrier against postoperative triple-negative breast cancer recurrence. Journal of Controlled Release,2020, 329, 191-204.
您当前位置： 